Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.06 USD | -0.28% | -4.71% | +29.18% |
09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.18% | 613.25Cr | |
+29.93% | 4.82TCr | |
-0.66% | 4.17TCr | |
+43.62% | 4.1TCr | |
-5.31% | 2.88TCr | |
+10.04% | 2.56TCr | |
-22.49% | 1.9TCr | |
+9.31% | 1.29TCr | |
+28.69% | 1.2TCr | |
-2.31% | 1.18TCr |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- HC Wainwright Adjusts Revolution Medicines' Price Target to $37 From $40, Reiterates Buy Rating